Literature DB >> 24218042

Pars plana vitrectomy for treatment of advanced Coats' disease--presentation of a modified surgical technique and long-term follow-up.

Daniela Suesskind1, Elke Altpeter, Merle Schrader, Karl U Bartz-Schmidt, Sabine Aisenbrey.   

Abstract

BACKGROUND: To present a modified surgical technique in the treatment of retinal detachment secondary to advanced Coats' disease in children, and report on long-term anatomical and functional outcome.
METHODS: We analysed an interventional case series of 13 patients (13 eyes) with advanced Coats' disease characterised by retinal detachment in addition to massive subretinal exudates and vascular malformation. The presented patients underwent pars plana vitrectomy (PPV), including a modified technique of exocryotherapy applied after fluid-air exchange in order to achieve complete treatment of the vascular changes, to reduce associated side-effects, and to avoid retinectomy and silicone oil tamponade.
RESULTS: Within a median follow-up period of 37 months (range: 18-66 months), no enucleation was necessary. Four eyes (31 %) did not need any further therapy, and in nine eyes (69 %) additional treatments were performed. Six patients (46 %) required revisional surgery with silicone oil tamponade. In ten eyes (77 %), the pathologic vessels and exudates finally regressed and the retina reattached. Visual acuity (VA) could be stabilized in the majority of patients: in three eyes (27 %) VA improved, in four eyes (36 %) VA remained stable, in four eyes (36 %) visual acuity (VA) deteriorated, and in two eyes VA could not be evaluated.
CONCLUSIONS: The presented modified technique allows for sufficient cryotherapy of vascular malformations, even in the presence of massive exudation, in a subset of patients with advanced Coats' disease, and thus may reduce surgery-related complications and improve the rehabilitation process of these young patients.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24218042     DOI: 10.1007/s00417-013-2512-3

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  30 in total

1.  Advanced Coats' disease successfully managed with vitreo-retinal surgery.

Authors:  G Kranias; T P Krebs
Journal:  Eye (Lond)       Date:  2002-07       Impact factor: 3.775

2.  Intravitreal triamcinolone in Coats' disease.

Authors:  Nicola G Ghazi; Hanan Al Shamsi; Jorgen Larsson; Emad Abboud
Journal:  Ophthalmology       Date:  2012-03       Impact factor: 12.079

3.  Resolution of total retinal detachment in Coats' disease with intravitreal injection of bevacizumab.

Authors:  Tong Zhao; Kai Wang; Yan Ma; Yan-Rong Jiang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-11-16       Impact factor: 3.117

4.  Use of intravitreal triamcinolone and bevacizumab in Coats' disease with central macular edema.

Authors:  Michael R R Böhm; Constantin E Uhlig
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-02-12       Impact factor: 3.117

5.  Coats' syndrome: long term follow up.

Authors:  D H Char
Journal:  Br J Ophthalmol       Date:  2000-01       Impact factor: 4.638

6.  A population-based study of Coats disease in the United Kingdom II: investigation, treatment, and outcomes.

Authors:  A Mulvihill; B Morris
Journal:  Eye (Lond)       Date:  2010-09-24       Impact factor: 3.775

7.  Effects of green diode laser in the treatment of pediatric Coats disease.

Authors:  Michael J Shapiro; Clement C Chow; Peter A Karth; Daniel F Kiernan; Michael P Blair
Journal:  Am J Ophthalmol       Date:  2011-01-22       Impact factor: 5.258

8.  Management of moderate to advanced Coats' disease.

Authors:  H Kiratli; B Eldem
Journal:  Ophthalmologica       Date:  1998       Impact factor: 3.250

9.  Clinical variations and complications of Coats disease in 150 cases: the 2000 Sanford Gifford Memorial Lecture.

Authors:  J A Shields; C L Shields; S G Honavar; H Demirci
Journal:  Am J Ophthalmol       Date:  2001-05       Impact factor: 5.258

10.  Pars plana vitrectomy in advanced coats' disease.

Authors:  Gulipek Muftuoglu; Gokhan Gulkilik
Journal:  Case Rep Ophthalmol       Date:  2011-01-07
View more
  5 in total

1.  Management of stage 3B Coats disease: presentation of a combined treatment modality and long-term follow-up.

Authors:  Tingyi Liang; Jie Peng; Qi Zhang; Xiuyu Zhu; Yu Xu; Peiquan Zhao
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-05-30       Impact factor: 3.117

2.  Treatment of stage 3 Coats' disease by endolaser photocoagulation via a two-port pars plana nonvitrectomy approach.

Authors:  Xuan Cai; Peiquan Zhao; Qi Zhang; Haiying Jin
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-03-21       Impact factor: 3.117

3.  An arched micro-injector (ARCMI) for innocuous subretinal injection.

Authors:  Yong Sung You; Chang Yeol Lee; Chengguo Li; Sung Ho Lee; Kibom Kim; Hyungil Jung
Journal:  PLoS One       Date:  2014-08-11       Impact factor: 3.240

4.  Evaluation of Follow-Up and Treatment Results in Coats' Disease.

Authors:  Zafer Cebeci; Şerife Bayraktar; Yusuf Cem Yılmaz; Samuray Tuncer; Nur Kır
Journal:  Turk J Ophthalmol       Date:  2016-10-17

5.  Combined treatment for Coats' disease: retinal laser photocoagulation combined with intravitreal bevacizumab injection was effective in two cases.

Authors:  Aya Kodama; Koji Sugioka; Shunji Kusaka; Chota Matsumoto; Yoshikazu Shimomura
Journal:  BMC Ophthalmol       Date:  2014-03-25       Impact factor: 2.209

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.